Clinical negligence revenue has climbed to £1.8 billion a year and is forecast to keep growing at around 7% annually for the next five years, according to new figures reported by Legal Futures. That sounds like unambiguous good news. It isn’t. Nearly 500 firms have left the clinical negligence market since summer 2022, leaving 1,224 still operating — and the top 10 firms alone now control 41.4% of the claimant cost market, with Irwin Mitchell taking 14% on its own.
The bigger picture: growing markets can still squeeze independent firms out
The instinct when a practice area is growing is to assume there’s more for everyone. Clinical negligence shows why that’s not how legal markets actually work. NHS Resolution logged a record 15,236 new claims last year, up 6% — real, growing client demand. But the firms capturing that growth are disproportionately the largest ones, because clinical negligence cases are notoriously slow and cash-intensive: years of disbursements on expert reports and case management before a penny comes back in costs. Firms with the strongest cash-flow capacity can simply outlast and outbid smaller competitors for the same cases.
This is a pattern independent law firms and high street law firms should recognise well beyond clinical negligence. Any practice area with long case durations, high upfront costs and complex evidentiary requirements tends to consolidate toward firms with the balance sheet to absorb the wait. Growing demand doesn’t protect smaller firms from being squeezed out of a market — it can accelerate the squeeze, because bigger competitors use rising volumes to justify further investment in acquiring exactly that specialism.
What independent solicitors need to know
For firms currently in, or considering, clinical negligence or any similarly cash-intensive practice area, three implications matter:
- Cash flow, not caseload, is now the real competitive constraint. A firm that wins the case but can’t fund it through to conclusion isn’t actually competing — it’s taking on risk it may not survive.
- Further fixed recoverable costs reform is a live threat. Any expansion of fixed costs into clinical negligence could push more small and mid-sized firms out entirely, accelerating the consolidation already under way.
- Specialisation and referral relationships matter more as the market concentrates. Firms that can’t compete on scale need to compete on reputation, speed of initial response, and being the obvious local choice for a specific type of claim.
The uncomfortable conclusion is that some independent firms in cash-heavy practice areas need to make a deliberate choice: invest to compete properly on volume and cash-flow capacity, partner or refer strategically with firms that have that capacity, or reposition toward practice areas where speed and client relationship — not balance sheet size — decide who wins the case.
There’s a wider lesson here for regional law firms weighing up any specialist expansion. Before chasing growth in a headline-grabbing practice area, it’s worth asking whether the economics actually suit your firm’s size — not just whether client demand is rising. A growing market with concentrating ownership is, in practice, a market that’s getting harder for smaller entrants to break into, not easier, however positive the topline revenue figures look in a trade press headline.
What forward-thinking firms are already doing
Firms protecting margin in consolidating markets are typically doing several things at once:
- Tightening case selection criteria so fee-earner time and disbursement spend go toward the strongest, most fundable claims rather than every enquiry that comes through the door
- Building referral networks with larger firms for cases beyond their cash-flow capacity, converting a case they can’t profitably run into a referral fee instead of a write-off
- Doubling down on practice areas — family, wills and probate, employment, smaller-value personal injury, conveyancing leads — where case duration and cost profiles suit an independent firm’s cash position far better than clinical negligence does
- Using specialist positioning and consistent local marketing to become the recognised go-to firm for a specific claim type, rather than competing head-on with national brands across every practice area
How this connects to growth
Profit protection in a consolidating market isn’t about winning more cases — it’s about winning the right cases, consistently, without over-extending cash flow. That’s a marketing and lead generation for law firms problem as much as a finance one. A steady, predictable stream of qualified conveyancing leads or family and probate enquiries does more for margin than an occasional large, slow-paying clinical negligence file that ties up working capital for three years.
Independent firms that get deliberate about which practice areas they actively market for — and which they quietly refer out — tend to run leaner, more predictable, more profitable practices than firms chasing every enquiry regardless of fit. That discipline matters more, not less, as national and PE-backed firms keep consolidating the cash-intensive end of the market.
If your firm is trying to work out which practice areas are actually worth marketing for given your cash position and case mix, GrowwithQS’s Lead Packs for Law Firms let you target qualified enquiries in the specific practice areas that suit your firm’s capacity — rather than absorbing whatever comes through the door.
